Internal Medicine, Nephrology · Dyersburg, TN
NPI
1548671845
Since 2014
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1575 Parr Ave Ste B
Dyersburg, TN, 38024
Phone (731) 286-1510
Groups this clinician bills Medicare through
Medicare paid, 2024
$562K
7,314 services
Medicare patients, 2024
1,529
Average age 74
Drug cost, 2024
$4.0M
5,597 prescriptions
Company payments, 2025
$21K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shree R Mulay was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,890 times for 1,115 patients. In total Shree R Mulay billed 7,314 services in 33 codes, and Medicare paid $562K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-29.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,890 | 1,115 | $12.04 | $23K |
| 99214 Office E&M - Established | Office | 1,247 | 817 | $72.20 | $90K |
| 90960 ESRD Related Services (not dialysis) | Office | 722 | 131 | $246.67 | $178K |
| 36415 Venipuncture Blood Collection | Office | 666 | 489 | $8.62 | $5,738 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 438 | 105 | $27.45 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 381 | 148 | $56.45 | $22K |
| 99215 Office E&M - Established | Office | 344 | 251 | $105.15 | $36K |
| 99204 Office E&M - New | Office | 265 | 265 | $117.48 | $31K |
| 90966 ESRD Related Services (not dialysis) | Office | 249 | 39 | $203.03 | $51K |
| 90961 ESRD Related Services (not dialysis) | Office | 176 | 86 | $202.55 | $36K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 145 | 34 | $40.74 | $5,908 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 107 | 56 | $33.63 | $3,598 |
| 90935 Hemodialysis | Facility | 95 | 48 | $50.86 | $4,832 |
| 99223 Hospital E&M - Initial | Facility | 95 | 85 | $120.26 | $11K |
| 99205 Office E&M - New | Office | 90 | 90 | $154.71 | $14K |
By year: 2022 $346K for 4,232 services; 2023 $393K for 5,160 services; 2024 $562K for 7,314 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 666 | 489 | $8.62 | $5,738 |
Medicare prescription drug claims, 2024
In 2024, the drug Shree R Mulay prescribed most often to Medicare patients was Losartan Potassium, with 403 prescriptions and refills. In total Shree R Mulay wrote 5,597 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 403 | 772 | 142 | $3,759 |
| Furosemide Generic | 351 | 589 | 118 | $1,566 |
| Carvedilol Generic | 351 | 655 | 118 | $2,278 |
| Sevelamer Carbonate Generic | 308 | 399 | 87 | $37K |
| Nifedipine Er Nifedipine | 266 | 451 | 88 | $5,192 |
| Famotidine Generic | 248 | 430 | 77 | $3,109 |
| Farxiga Dapagliflozin Propanediol | 245 | 377 | 73 | $204K |
| Amlodipine Besylate Generic | 239 | 428 | 80 | $1,007 |
| Calcium Acetate Generic | 235 | 389 | 90 | $15K |
| Calcitriol Generic | 217 | 441 | 85 | $2,639 |
| Valsartan Generic | 184 | 325 | 64 | $4,720 |
| Hydralazine Hcl Generic | 183 | 299 | 62 | $2,083 |
| Entresto Sacubitril/Valsartan | 140 | 205 | 32 | $116K |
| Lisinopril Generic | 123 | 239 | 42 | $581 |
| Kerendia Finerenone | 113 | 191 | 31 | $124K |
Brand drugs: - claims; generic drugs: 4,337 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shree R Mulay $21K ($21K in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $11K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 20 | $11K |
| Scpharmaceuticals Inc. SCPH | 2 | $8,757 |
| Daxor Corporation DXR | 1 | $300 |
| Renalytix AI, Inc. | 3 | $141 |
| Ardelyx, Inc. ARDX | 2 | $140 |
| Fresenius USA Marketing, Inc. | 7 | $118 |
| Travere Therapeutics, Inc. TVTX | 4 | $99.92 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $92.94 |
| Novo Nordisk Inc NVO | 1 | $72.28 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $56.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.